Literature DB >> 31584367

Nanomedicines to Treat Skin Pathologies with Natural Molecules.

Elisabetta Esposito1, Claudio Nastruzzi1, Maddalena Sguizzato1, Rita Cortesi1.   

Abstract

The skin and mucous membranes are subjected to many disorders and pathological conditions. Nature offers a wide range of molecules with antioxidant activity able to neutralize, at least in part, the formation of free radicals and therefore to counteract the phenomena of cellular aging. Since synthetic drugs for the treatment of skin diseases can induce resistance, it is particularly interesting to use compounds of plant origin, transporting them in pharmaceutical forms capable of controlling their release and absorption. This review provides an overview of new findings about the use of lipid-based nanosystems for the delivery of natural molecules useful on the topical treatment of skin disorders. Several natural molecules encapsulated in lipid nanosystems have been considered in the treatment of some skin pathologies or diseases. Particularly, the use of rosemary and eucalyptus essential oil, saffron derivatives, curcumin, eugenol, capsaicin, thymol and lycopene has been reported. The molecules have been alternatively encapsulated in viscous systems, such as the organogels, or in liquid systems, such as ethosomes, transferosomes, solid lipid nanoparticles and monoolein based dispersions thickened by inclusion in carbomer gels. The nanostructured forms have been in vitro and in vivo investigated for the treatment of skin disorders due to dehydration, inflammation, melanoma, wound healing, fungal infections or psoriasis. The data reported in the different studies have suggested that the cutaneous application of lipid nanosystems allows a deep interaction between lipid matrix and skin strata, promoting a prolonged release and efficacy of the loaded natural molecules. This review suggests that the application of natural molecules onto the skin by lipid-based nanosystems can provide numerous clinician benefits in dermatology and cosmetics. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Skin; cubic phase; cubosome; cutaneous application; ethosome; nanotechnology; natural molecules; solid lipid nanoparticle.

Mesh:

Substances:

Year:  2019        PMID: 31584367     DOI: 10.2174/1381612825666190709210703

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  5 in total

1.  A Combined Cyanine/Carbomer Gel Enhanced Photodynamic Antimicrobial Activity and Wound Healing.

Authors:  Ming Guan; Guangyu Chu; Jiale Jin; Can Liu; Linxiang Cheng; Yi Guo; Zexing Deng; Yue Wang
Journal:  Nanomaterials (Basel)       Date:  2022-06-24       Impact factor: 5.719

Review 2.  Cyano-Phycocyanin: Mechanisms of Action on Human Skin and Future Perspectives in Medicine.

Authors:  Daiva Dranseikienė; Gabrielė Balčiūnaitė-Murzienė; Jūratė Karosienė; Dmitrij Morudov; Nomeda Juodžiukynienė; Nataliia Hudz; Rima Jūratė Gerbutavičienė; Nijolė Savickienė
Journal:  Plants (Basel)       Date:  2022-05-05

Review 3.  Phospholipid Vesicles for Dermal/Transdermal and Nasal Administration of Active Molecules: The Effect of Surfactants and Alcohols on the Fluidity of Their Lipid Bilayers and Penetration Enhancement Properties.

Authors:  Hiba Natsheh; Elka Touitou
Journal:  Molecules       Date:  2020-06-27       Impact factor: 4.411

4.  The Potential of Caffeic Acid Lipid Nanoparticulate Systems for Skin Application: In Vitro Assays to Assess Delivery and Antioxidant Effect.

Authors:  Supandeep Singh Hallan; Maddalena Sguizzato; Markus Drechsler; Paolo Mariani; Leda Montesi; Rita Cortesi; Sebastian Björklund; Tautgirdas Ruzgas; Elisabetta Esposito
Journal:  Nanomaterials (Basel)       Date:  2021-01-12       Impact factor: 5.076

Review 5.  Topical Administration of Drugs Incorporated in Carriers Containing Phospholipid Soft Vesicles for the Treatment of Skin Medical Conditions.

Authors:  Elka Touitou; Hiba Natsheh
Journal:  Pharmaceutics       Date:  2021-12-10       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.